# Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

> **NCT00514228** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 45 (actual)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** sunitinib malate

## Key facts

- **NCT ID:** NCT00514228
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-08
- **Final completion:** 2009-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00514228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00514228, "Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00514228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*